sacituzumab govitecan
gilead sciences
['tropics02']
dr di ras offers her strengths and concerns on #tropics02 and ultimately advocates for early assessment of adverse events and better understanding of target expression &amp; efficacy #asco22 
Director Breast Oncology, Lifespan Cancer Institute, Legorreta Cancer Center Brown Univ | Medical Advisor @drloveresearch | #bcsm #clinicaltrials | Views Mine